These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 7936543
21. [Cardiovascular risk factors and prevention in women: similarities and differences]. Sclavo M. Ital Heart J Suppl; 2001 Feb; 2(2):125-41. PubMed ID: 11255880 [Abstract] [Full Text] [Related]
22. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Dubey RK, Imthurn B, Barton M, Jackson EK. Cardiovasc Res; 2005 May 01; 66(2):295-306. PubMed ID: 15820198 [Abstract] [Full Text] [Related]
23. [Hormone replacement therapy at menopause in the diabetic woman]. Berthezène F. Diabetes Metab; 2001 Sep 01; 27(4 Pt 2):S83-6. PubMed ID: 11787443 [Abstract] [Full Text] [Related]
24. Osteoporosis and cardiovascular disease: benefit-risk of hormone replacement therapy. Sammartino A, Cirillo D, Mandato VD, Di Carlo C, Nappi C. J Endocrinol Invest; 2005 Sep 01; 28(10 Suppl):80-4. PubMed ID: 16550729 [Abstract] [Full Text] [Related]
25. Hormone replacement therapy and cardiovascular risk in post-menopausal women with NIDDM. Sattar N, Jaap AJ, MacCuish AC. Diabet Med; 1996 Sep 01; 13(9):782-8. PubMed ID: 8891452 [Abstract] [Full Text] [Related]
26. Evaluation and management of the hormone replacement therapy (HRT) candidate. Hillard T. Int J Fertil Womens Med; 1997 Sep 01; 42 Suppl 2():347-64. PubMed ID: 9397383 [Abstract] [Full Text] [Related]
27. A review of the association of estrogens and progestins with cardiovascular disease in postmenopausal women. Psaty BM, Heckbert SR, Atkins D, Siscovick DS, Koepsell TD, Wahl PW, Longstreth WT, Weiss NS, Wagner EH, Prentice R. Arch Intern Med; 1993 Jun 28; 153(12):1421-7. PubMed ID: 8512434 [Abstract] [Full Text] [Related]
28. A decision tree for the use of estrogen replacement therapy or hormone replacement therapy in postmenopausal women: consensus opinion of The North American Menopause Society. Menopause; 2000 Jun 28; 7(2):76-86. PubMed ID: 10746889 [Abstract] [Full Text] [Related]
29. The medical management of menopause: to treat or not to treat? Barlow DH. Ann N Y Acad Sci; 2008 Apr 28; 1127():134-9. PubMed ID: 18443341 [Abstract] [Full Text] [Related]
30. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Skouby SO, Al-Azzawi F, Barlow D, Calaf-Alsina Erdogan Ertüngealp J, Gompel A, Graziottin A, Hudita D, Pines A, Rozenberg S, Samsioe G, Stevenson JC, European Menopause and Andropause Society. Maturitas; 2005 May 16; 51(1):8-14. PubMed ID: 15883103 [Abstract] [Full Text] [Related]
31. Baseline characteristics of menopausal women with coronary heart disease in cardiovascular outcomes clinical trials of menopausal hormone therapy or raloxifene. Wenger NK, Geiger MJ. Contemp Clin Trials; 2005 Dec 16; 26(6):612-5. PubMed ID: 16257585 [Abstract] [Full Text] [Related]
32. The effects of smoking on estradiol metabolism. Tansavatdi K, McClain B, Herrington DM. Minerva Ginecol; 2004 Feb 16; 56(1):105-14. PubMed ID: 14973414 [Abstract] [Full Text] [Related]
38. [Coronary disease risk in menopausal women]. Chojnowska-Jezierska J. Pol Tyg Lek; 1980 May 26; 35(21):787-9. PubMed ID: 7413504 [No Abstract] [Full Text] [Related]
39. Current trends in hormone replacement therapy. Khashoggi TY. Saudi Med J; 2002 May 26; 23(5):495-502. PubMed ID: 12070567 [Abstract] [Full Text] [Related]